FDA Releases Draft Guidance for Companion Diagnostic Devices for Oncology Therapeutic Products

Summary

The FDA has released a draft guidance for industry on developing and labeling in vitro companion diagnostic devices to support the use of multiple oncology therapeutic products, aiming to facilitate clinical use with broader evidence-based indications.